IMP cyclohydrolase Monoclonal Antibody, 50ul Lentiviral Packaging including Brugada syndrome and short
Pay in 4 interest-free payments of $46.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Live Spec
IMP cyclohydrolase Monoclonal Antibody, 50ul Lentiviral Packaging including Brugada syndrome and shortThis gene encodes a bifunctional protein that catalyzes the last two steps of the de novo purine biosynthetic pathway. The N terminal domain has phosphoribosylaminoimidazolecarboxamide formyltransferase activity, and the C terminal domain has IMP cyclohydrolase activity. A mutation in this gene results in AICA ribosiduria.
Store: www.slt-gutachten.at · Domain: www.slt-gutachten.at

























